Alvotech announced positive topline results from a confirmatory clinical study for AVT 05, Alvotech’s proposed biosimilar to Simponi and Simponi Aria (golimumab)
See all upcoming medical congress for Healthcare Professionals on Medthority
This study will assess the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin (M+P) in participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL)...
Insightful analysis from international specialists
Containing relevant Learning Zones, guidelines, trials and news.
Axsome Therapeutics announced that AXS 05 (bupropion + dextromethorphan) met the primary endpoint and rapidly and significantly improved symptoms of...